Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The state government on Friday sought to silence doubters to claim that the Drug Reduction Elimination & Action Mission ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous ...

Elicio Therapeutics aims for breakthrough treatment with ELI-002 in pancreatic cancer. Find out why ELTX stock may benefit ...

Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Kennedy wants to create "wellness drug rehabilitation farms." But the U.S. tried it before, and it didn't work.

I have been seeking recovery from alcohol, heroin and pharmaceutical opioid use disorders since late 2013. The treatment system is fraught with barriers, especially so if you’re ...

It was about a year ago that shares of Iovance Biotherapeutics (NASDAQ: IOVA) began to take off. Could this be a great buying ...